We are live on
!
Find out more
Winslow Capital Management Portfolio holdings
AUM
$25.6B
1-Year Est. Return
33.75%
This Fund
S&P 500
This Quarter
Est. Return
+11.37%
1 Year Est. Return
+33.75%
3 Year Est. Return
+154.66%
5 Year Est. Return
+213.06%
10 Year Est. Return
+1,176.99%
AUM
$19.3B
AUM Growth
+$943M
(+5.1%)
Cap. Flow
-$839M
Cap. Flow
% of AUM
-4.36%
Top 10 Holdings %
Top 10 Hldgs %
45.4%
Holding
60
New
4
Increased
13
Reduced
34
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$336M |
| 2 |
Boston Scientific
BSX
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$185M |
| 4 |
3M
MMM
|
+$174M |
| 5 |
Alibaba
BABA
|
+$99.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$306M |
| 2 |
Northrop Grumman
NOC
|
+$256M |
| 3 |
Intuitive Surgical
ISRG
|
+$252M |
| 4 |
Mercado Libre
MELI
|
+$183M |
| 5 |
PagSeguro Digital
PAGS
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.72% |
| 2 | Consumer Discretionary | 18.58% |
| 3 | Healthcare | 13.73% |
| 4 | Financials | 12.01% |
| 5 | Communication Services | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CAE Inc. Common Shares
CAE
$8.62B
| $1.8M | 0.01% |
67,800
| – | – |
|
|
TBHC
52
DELISTED
The Brand House Collective
TBHC
| $1.54M | 0.01% |
34,960
| – | – |
|
53
Merck
MRK
$317B
| $1.28M | 0.01% |
14,745
-451
| -3% | -$37K |
|
54
Agilent Technologies
A
$39.9B
| $1.06M | 0.01% |
12,448
+1,684
| +16% | +$133K |
|
|
55
Intuitive Surgical
ISRG
$133B
| – | – |
-1,400,316
| Closed | -$252M |
|
|
56
Mercado Libre
MELI
$97.5B
| – | – |
-332,662
| Closed | -$183M |
|
|
57
Northrop Grumman
NOC
$79.2B
| – | – |
-681,959
| Closed | -$256M |
|
|
58
PagSeguro Digital
PAGS
$2.63B
| – | – |
-3,712,969
| Closed | -$172M |
|
|
59
Stryker
SYK
$129B
| – | – |
-1,413,403
| Closed | -$306M |
|
|
XLNX
60
DELISTED
Xilinx Inc
XLNX
| – | – |
-1,675,569
| Closed | -$161M |
|
Similar funds
UIM
VAI
KK
Winslow Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Winslow Capital Management held 60 positions worth $19.3B, up 5.1% from $18.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Winslow Capital Management withdrew a net $839M in Q4 2019, closing 6 positions and reducing 34 holdings. Its most notable exit was Stryker, an estimated $306M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Winslow Capital Management opened a new position in Amgen worth $367M.
- Winslow Capital Management's largest Q4 2019 buy was Amgen: 1,523,938 shares worth $367M.
- Winslow Capital Management added most to Alibaba in Q4 2019, an estimated $99.5M increase.
- Winslow Capital Management's biggest Q4 2019 reduction was Zoetis, cutting an estimated $128M.
- Winslow Capital Management fully exited Stryker in Q4 2019, selling an estimated $306M.
- Winslow Capital Management's ten largest holdings make up 45% of its $19.3B portfolio in Q4 2019.
- Winslow Capital Management opened 4 new positions and closed 6 in Q4 2019.
- Winslow Capital Management's portfolio value rose 5.1% quarter-over-quarter to $19.3B.
Based on Winslow Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.